Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 27, 2012Antimicrobial Agents and ChemotherapyOpen Access

Pan-β-Lactam Resistance Development in Pseudomonas aeruginosa Clinical Strains: Molecular Mechanisms, Penicillin-Binding Protein Profiles, and Binding Affinities

View Full Paper
Ask AI
Bookmark
Share

Authors

BMBartolomé MoyáHealth Research Institute of the Balearic IslandsABAlejandro BeceiroUniversidade da CoruñaGCGabriel CabotInstituto de Salud Carlos III

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Moyá et al. (2012) studied this question.

synapsesocial.com/papers/6a70a77ffebe604dd7096ce7https://doi.org/10.1128/aac.00680-12
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Activity of a New Cephalosporin, CXA-101 (FR264205), against β-Lactam-Resistant Pseudomonas aeruginosa Mutants Selected In Vitro and after Antipseudomonal Treatment of Intensive Care Unit Patients2010 · 111 citations
  2. 2Activity of a New Antipseudomonal Cephalosporin, CXA-101 (FR264205), against Carbapenem-Resistant and Multidrug-Resistant Pseudomonas aeruginosa Clinical Strains2009 · 99 citations
  3. 3Imipenem resistance in clinical isolates of Proteus mirabilis associated with alterations in penicillin-binding proteins1995 · 86 citations
  4. 4Substrate Specificities of MexAB-OprM, MexCD-OprJ, and MexXY-OprM Efflux Pumps in Pseudomonas aeruginosa2000 · 730 citations
  5. 5Potent activity of meropenem against Escherichia coli arising from its simultaneous binding to penicillin-binding proteins 2 and 31995 · 53 citations